Sale!

SLC2A1 Gene DYT8 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC2A1 gene, also known as the solute carrier family 2 member 1 gene, plays a crucial role in the human body by facilitating the transport of glucose across the blood-brain barrier. Mutations in the SLC2A1 gene are associated with various neurological disorders, including DYT8, also known as Paroxysmal Exercise-Induced Dyskinesia (PED). This condition is characterized by abnormal, involuntary movements triggered by physical exertion or prolonged exercise.

The DYT8 genetic test specifically looks for mutations in the SLC2A1 gene to confirm a diagnosis of PED. This test is crucial for individuals exhibiting symptoms of DYT8, as it helps in the accurate diagnosis and management of the condition. Early detection through genetic testing can lead to better management of symptoms and improve the quality of life for those affected.

In the United Arab Emirates, DNA Labs UAE offers the SLC2A1 gene DYT8 genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals experienced in genetic diagnostics. They ensure that the testing process is efficient and results are accurate and reliable, providing crucial information for patients and their families dealing with DYT8.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC2A1 Gene DYT8 Genetic Test

At DNA Labs UAE, we offer the SLC2A1 Gene DYT8 Genetic Test for individuals who may be experiencing symptoms of DYT8 dystonia. This test is designed to identify any mutations or variations in the SLC2A1 gene that may be contributing to the movement disorder.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the SLC2A1 Gene DYT8 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members who may be affected by the condition.

Test Details

The SLC2A1 gene, also known as the glucose transporter type 1 (GLUT1) gene, is associated with DYT8 dystonia. This movement disorder is characterized by involuntary muscle contractions that result in twisting and repetitive movements or abnormal postures.

NGS (next-generation sequencing) genetic testing is used to analyze multiple genes simultaneously, including the SLC2A1 gene. This type of testing helps in diagnosing DYT8 dystonia and identifying any mutations or variations in the SLC2A1 gene that may be contributing to the disorder.

Individuals with DYT8 dystonia can benefit from NGS genetic testing as it confirms the diagnosis and provides information for treatment options. Additionally, family members who may be at risk of inheriting the condition can also benefit from genetic testing.

For more information or to schedule a SLC2A1 Gene DYT8 Genetic Test, please contact our Genetics Test Department.

Test Name SLC2A1 Gene DYT8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC2A1 Gene DYT8 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC2A1 Gene DYT8
Test Details

The SLC2A1 gene, also known as the glucose transporter type 1 (GLUT1) gene, is associated with a movement disorder called DYT8 dystonia. This disorder is characterized by involuntary muscle contractions that cause twisting and repetitive movements or abnormal postures.

NGS (next-generation sequencing) genetic testing is a method of DNA sequencing that allows for the simultaneous analysis of multiple genes, including the SLC2A1 gene. This type of testing can help diagnose DYT8 dystonia and identify any mutations or variations in the SLC2A1 gene that may be contributing to the disorder.

Individuals with DYT8 dystonia may benefit from NGS genetic testing to confirm the diagnosis and inform treatment options. Genetic testing can also be helpful for family members of affected individuals who may be at risk of inheriting the condition.